These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 989135)

  • 41. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.
    Small PM; Chambers HF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1227-31. PubMed ID: 2393284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of antimicrobial agents in the rabbit model of endocarditis.
    Sande MA
    Rev Infect Dis; 1981; 3 suppl():S240-9. PubMed ID: 7342288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vancomycin therapy for infective endocarditis.
    Geraci JE; Wilson WR
    Rev Infect Dis; 1981; 3 suppl():S250-8. PubMed ID: 7342289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Leclercq R; Duval J; Carbon C
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
    Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Lodise TP; McKinnon PS; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.
    Levine DP; Fromm BS; Reddy BR
    Ann Intern Med; 1991 Nov; 115(9):674-80. PubMed ID: 1929035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
    J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis.
    Bruss JB
    Clin Infect Dis; 2009 Sep; 49(5):806; author reply 807-8. PubMed ID: 19653850
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
    Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C
    Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
    Mortara LA; Bayer AS
    Infect Dis Clin North Am; 1993 Mar; 7(1):53-68. PubMed ID: 8463653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Failure of medical therapy in tricuspid endocarditis due to Staphylococcus aureus.
    Geiseler PJ; Rice TW; McCulley DJ; Lewis SM; Berzins BL
    Chemotherapy; 1984; 30(6):408-12. PubMed ID: 6518837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vancomycin failure in staphylococcal endocarditis.
    Jackson MA; Hicks RA
    Pediatr Infect Dis J; 1987 Aug; 6(8):750-2. PubMed ID: 3499592
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG; Durack DT
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of bacterial endocarditis with vancomycin.
    Cook FV; Coddington CC; Wadland WC; Farrar WE
    Am J Med Sci; 1978; 276(2):153-8. PubMed ID: 104623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.